Dementia with Lewy bodies (DLB) may not be as well-known as other forms like Alzheimer’s ... the new data backs up an earlier finding that the drug class seems to reduce the risk of Parkinson ...
UUI is more common in older females and the most common form of urinary incontinence in ... There is no specific drug treatment for OUI, but people with an enlarged prostate may benefit from ...
Alfuzosin is contraindicated in patients with a hypersensitivity to alfuzosin or other quinazolones. Alfuzosin should be used cautiously in patients who are predisposed to hypotension, including ...
[68] Similar to terazosin, alfuzosin is more effective than finasteride, and an alfuzosin-finasteride combination does not appear to be more effective than alfuzosin alone. Debruyne et al.
It is available in two forms: Tobi and Tobi Podhaler. Tobi and Tobi Podhaler contain the active ingredient tobramycin and are part of the drug class called aminoglycoside antibiotic. This article ...
The recommended trazodone dosage for major depressive disorder (MDD) is between 150 milligrams (mg) and 400 mg. Trazodone is an oral tablet that you typically take in divided doses. It is ...
The Centers for Medicare & Medicaid Services announced 15 new drugs it wants to lower the cost for, including popular, but ...
Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.
Mounjaro (tirzepatide) is a prescription drug that’s used to treat type 2 diabetes. The drug comes as a liquid solution that you inject under your skin, typically once per week. Mounjaro ...
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
Create forms, collect data, and analyse it easily with these platforms. All of the best online form builders we list below make it easy to collect customer feedback and marketing data with forms ...